Related Experiment Videos
[Acute ulcer hemorrhage: when to operate--when to wait?]
1Robert-Bosch-Krankenhaus Stuttgart, Abteilung für Allgemein- und Unfallchirurgie.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|July 28, 1992
Summary
A new treatment strategy for bleeding peptic ulcers, guided by endoscopic risk assessment, significantly reduced mortality rates. This approach prioritizes surgery for high-risk patients, improving outcomes for bleeding peptic ulcer disease.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Clinical Medicine
Context:
- Peptic ulcer bleeding poses significant mortality risks.
- Recurrent bleeding is a major determinant of poor outcomes.
- Effective prognostic factor identification is crucial for treatment optimization.
Purpose:
- To develop and evaluate a novel treatment policy for bleeding peptic ulcers based on prognostic factors identified during emergency endoscopy.
- To reduce the mortality rate associated with bleeding peptic ulcer disease.
Summary:
- A prospective trial implemented a new treatment strategy for bleeding peptic ulcers.
- High-risk patients with actively bleeding lesions or visible vessels underwent timely surgery (within 6-24 hours), even after endoscopic hemostasis.
- Lower-risk patients received conservative management.
Impact:
- The new strategy markedly reduced the overall mortality rate from 14% to 5%.
- This demonstrates the clinical utility of risk-stratified management in bleeding peptic ulcer patients.